Both cardiac biomarkers (High-sensitivity Troponin T (Hs-TnT)), and N-terminal pro–B-type natriuretic peptide (NT-proBNP)), and inflammatory biomarkers (Interleukin-6 (IL-6) and Procalcitonin (PCT)) have been associated with (COVID-19) disease severity and mortality [12–20]. This evidence concerns the gene IL6 and COVID-19.